AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2015
Apr 30, 2015
34983_dirs_2015-04-30_a5fbf3f3-f80b-4a56-a57c-1c9b8703b5bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20
Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-29 | Common Shares | P | 25700 | $0.144 | Acquired | 3554494 | Direct |
| 2015-04-29 | Common Shares | P | 21300 | $0.14 | Acquired | 3575794 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 4318958 | Indirect |
| Common Shares | 3528794 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $0.11 | 2019-12-23 | Common Shares (500000) | 500000 | Direct |
| Stock Options | $0.35 | 2016-07-11 | Common Shares (200000) | 700000 | Direct |
| Stock Options | $0.1 | 2018-06-18 | Common Shares (225000) | 925000 | Direct |
| Warrants | $0.25 | 2015-09-21 | Common Shares (100067) | 1025067 | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19